Zacks Investment Research Lowers American Vanguard Corporation (AVD) to Sell
Zacks Investment Research cut shares of American Vanguard Corporation (NYSE:AVD) from a hold rating to a sell rating in a research note issued to investors on Tuesday.
According to Zacks, “AMERICAN VANGUARD CORP. is a holding company, which through its subsidiaries, is engaged in the manufacturer and formulation of chemicals for crops, human and animal health protection. These chemicals which include insecticides, fungicides, molluscicides, growth regulatorsain, and soil fumigants, are marketed in liquid, powder, and granular forms. “
A number of other brokerages also recently commented on AVD. Roth Capital set a $28.00 target price on American Vanguard Corporation and gave the company a buy rating in a research note on Sunday, October 1st. Piper Jaffray Companies set a $22.00 target price on American Vanguard Corporation and gave the company a hold rating in a research note on Friday, October 6th. Finally, BidaskClub upgraded American Vanguard Corporation from a strong sell rating to a sell rating in a research note on Thursday, August 10th. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating, one has given a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of Hold and a consensus price target of $25.33.
American Vanguard Corporation (NYSE AVD) opened at $19.25 on Tuesday. The company has a quick ratio of 1.20, a current ratio of 2.37 and a debt-to-equity ratio of 0.19. American Vanguard Corporation has a 52 week low of $14.65 and a 52 week high of $24.00. The company has a market capitalization of $573.55, a P/E ratio of 35.19, a price-to-earnings-growth ratio of 2.13 and a beta of 1.30.
American Vanguard Corporation (NYSE:AVD) last issued its earnings results on Thursday, November 2nd. The basic materials company reported $0.14 EPS for the quarter, missing the Zacks’ consensus estimate of $0.17 by ($0.03). American Vanguard Corporation had a net margin of 4.83% and a return on equity of 5.44%. The company had revenue of $90.00 million during the quarter, compared to analyst estimates of $89.17 million. During the same quarter in the previous year, the firm earned $0.10 earnings per share. The business’s revenue was up 9.2% on a year-over-year basis. equities research analysts predict that American Vanguard Corporation will post 0.59 EPS for the current year.
WARNING: This piece of content was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2017/11/18/zacks-investment-research-lowers-american-vanguard-corporation-avd-to-sell.html.
The firm also recently declared a quarterly dividend, which was paid on Thursday, October 19th. Stockholders of record on Thursday, October 5th were issued a dividend of $0.015 per share. The ex-dividend date was Wednesday, October 4th. This represents a $0.06 dividend on an annualized basis and a dividend yield of 0.31%. American Vanguard Corporation’s dividend payout ratio (DPR) is presently 11.32%.
Several institutional investors and hedge funds have recently added to or reduced their stakes in AVD. Macquarie Group Ltd. bought a new stake in shares of American Vanguard Corporation during the third quarter valued at approximately $141,000. Acrospire Investment Management LLC raised its holdings in shares of American Vanguard Corporation by 83.7% during the second quarter. Acrospire Investment Management LLC now owns 8,685 shares of the basic materials company’s stock valued at $150,000 after buying an additional 3,956 shares during the last quarter. Victory Capital Management Inc. bought a new stake in shares of American Vanguard Corporation during the third quarter valued at approximately $153,000. BNP Paribas Arbitrage SA raised its holdings in shares of American Vanguard Corporation by 54.0% during the second quarter. BNP Paribas Arbitrage SA now owns 9,019 shares of the basic materials company’s stock valued at $156,000 after buying an additional 3,162 shares during the last quarter. Finally, Louisiana State Employees Retirement System raised its holdings in shares of American Vanguard Corporation by 1.9% during the second quarter. Louisiana State Employees Retirement System now owns 10,700 shares of the basic materials company’s stock valued at $185,000 after buying an additional 200 shares during the last quarter. 76.30% of the stock is currently owned by institutional investors.
About American Vanguard Corporation
American Vanguard Corporation operates as a holding company. The Company conducts its business through its subsidiaries, AMVAC Chemical Corporation (AMVAC), GemChem, Inc (GemChem), 2110 Davie Corporation (DAVIE), Quimica Amvac de Mexico SA de C.V. (AMVAC M), AMVAC Mexico Sociedad de Responsabilidad Limitada (AMVAC M Srl), AMVAC de Costa Rica Sociedad de Responsabilidad Limitada (AMVAC CR Srl), AMVAC Switzerland GmbH (AMVAC S), AMVAC do Brasil Representacoes Ltda (AMVAC B), AMVAC C.V.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for American Vanguard Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard Corporation and related stocks with our FREE daily email newsletter.